NeuroXess
NeuroXess appears in 7 analyzed articles across the measured technology press. Recent coverage is steady, counting every mention over recent months. This page shows the public snapshot: movement, coverage mix, recent sources, and what drove the latest change.
Compass measures press coverage, not NeuroXess's product quality, business performance, or market value.
Counting every mention, coverage of NeuroXess is steady — it appears in 7 analyzed articles across the technology press.
What NeuroXess coverage is made of over time: story type, claim stage as reported, and press framing. This measures the coverage, not the product.
Across 6 classified coverage items, one item is 17 percentage points — read the shares below as the shape of a small sample, not as figures precise to the point.
Story type and claim stage are shares of the 6 classified coverage items in this window.
How to read this
The stream below stacks each month's coverage by the lens you choose: Tone (how the press frames the story — promotional, skeptical, critical, or neutral), Story type (launches, funding, lawsuits, partnerships…), or Stage — how far the reported claim has gone: speculation → announcement → launch → results.
Taller bands mean more coverage that month; the dots beneath mark notable non‑neutral events. Every signal is sourced and dated.
How this is counted — why the article numbers differ
7 articles mention NeuroXess across the corpus. The coverage make-up above is measured on the 3 of them that were read into dated, classified coverage items — and one article can produce more than one item, because story type, claim stage and framing are read separately.
- report NeuroXess raised RMB 700 million in Series B funding co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital.
- Shanghai-based NeuroXess, which is developing BCI technology for movement support, speech decoding, and control of external devices, raised a ~$105M Series B (TechNode)Techmeme
- Brain-computer interface startup NeuroXess raises RMB 700 million in Series B fundingTechNode
- China brain computer interface outfit accelerates to human trials in quest to outpace Neuralink — mix of government backing and investor enthusiasm speeds time to market for NeuroXessTom's Hardware
As of 22 Nov 2026 · corpus coverage 94% · 387,661 articles. Correlational & coverage-limited.
- ✓
This snapshotDirection, footprint & coverage make-up — free, no account, always
- 🔒
Full history & coverage trailMonth-by-month make-up & every cited source
- 🔒
ConnectionsThe topics it's most often covered alongside
- 🔒
Compare & exportBenchmark vs. other topics; export the source pack
- 🔒
Watchlist & alertsGet pinged when the make-up or direction shifts